INOVIO PHARMACEUTICALS, INC. Operating Expenses
INOVIO PHARMACEUTICALS, INC. (INO) reported Operating Expenses of $18.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-12
- INOVIO PHARMACEUTICALS, INC. operating expenses for the quarter ending 2026-06-30 was $18.62M, a 19.32% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. operating expenses for the quarter ending 2026-03-31 was $21.95M, a 12.61% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. operating expenses for the quarter ending 2025-12-31 was $17.48M, a 14.69% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. operating expenses for the quarter ending 2025-09-30 was $21.21M, a 22.44% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. operating expenses for fiscal 2025 was $86.89M, a 22.85% decline from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. operating expenses for fiscal 2024 was $112.62M, a 22.21% decline from fiscal 2023.
- INOVIO PHARMACEUTICALS, INC. operating expenses for fiscal 2023 was $144.77M, a 47.89% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. operating expenses for fiscal 2022 was $277.84M, a 8.30% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.62M 10-Q · filed 2026-08-12 | $40.57M 10-Q · filed 2026-08-12 | $58.05M derived: sum of 3 quarters · filed 2026-08-12 | $79.26M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $21.95M 10-Q · filed 2026-05-13 | $39.43M derived: sum of 2 quarters · filed 2026-05-13 | $60.64M derived: sum of 3 quarters · filed 2026-05-13 | $83.72M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $17.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $38.69M derived: sum of 2 quarters · filed 2026-03-12 | $61.77M derived: sum of 3 quarters · filed 2026-08-12 | $86.89M 10-K · filed 2026-03-12 |
| 2025-09-30 | $21.21M 10-Q · filed 2025-11-10 | $44.29M derived: sum of 2 quarters · filed 2026-08-12 | $69.41M 10-Q · filed 2025-11-10 | $89.90M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $23.08M 10-Q · filed 2026-08-12 | $48.20M 10-Q · filed 2026-08-12 | $68.69M derived: sum of 3 quarters · filed 2026-08-12 | $96.03M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $25.12M 10-Q · filed 2026-05-13 | $45.60M derived: sum of 2 quarters · filed 2026-05-13 | $72.95M derived: sum of 3 quarters · filed 2026-05-13 | $106.25M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $20.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $47.83M derived: sum of 2 quarters · filed 2026-03-12 | $81.13M derived: sum of 3 quarters · filed 2026-03-12 | $112.62M 10-K · filed 2026-03-12 |
| 2024-09-30 | $27.35M 10-Q · filed 2025-11-10 | $60.65M derived: sum of 2 quarters · filed 2025-11-10 | $92.13M 10-Q · filed 2025-11-10 | $119.63M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $33.30M 10-Q · filed 2025-08-12 | $64.78M 10-Q · filed 2025-08-12 | $92.28M derived: sum of 3 quarters · filed 2025-08-12 | $128.22M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $31.48M 10-Q · filed 2025-05-13 | $58.98M derived: sum of 2 quarters · filed 2025-05-13 | $94.92M derived: sum of 3 quarters · filed 2025-05-13 | $132.19M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $27.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $63.44M derived: sum of 2 quarters · filed 2025-03-18 | $100.70M derived: sum of 3 quarters · filed 2025-03-18 | $144.77M 10-K · filed 2025-03-18 |
| 2023-09-30 | $35.94M 10-Q · filed 2024-11-14 | $73.21M derived: sum of 2 quarters · filed 2024-11-14 | $117.28M 10-Q · filed 2024-11-14 | $173.35M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $37.27M 10-Q · filed 2024-08-08 | $81.33M 10-Q · filed 2024-08-08 | $137.41M derived: sum of 3 quarters · filed 2024-08-08 | $182.32M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $44.07M 10-Q · filed 2024-05-13 | $100.14M derived: sum of 2 quarters · filed 2024-05-13 | $145.05M derived: sum of 3 quarters · filed 2024-05-13 | $249.97M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $56.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $100.98M derived: sum of 2 quarters · filed 2024-03-06 | $205.90M derived: sum of 3 quarters · filed 2024-03-06 | $277.84M 10-K · filed 2024-03-06 |
| 2022-09-30 | $44.91M 10-Q · filed 2023-11-09 | $149.83M derived: sum of 2 quarters · filed 2023-11-09 | $221.76M 10-Q · filed 2023-11-09 | $328.11M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | $104.92M 10-Q · filed 2023-08-09 | $176.85M 10-Q · filed 2023-08-09 | $283.20M derived: sum of 3 quarters · filed 2024-03-06 | $343.45M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-03-31 | $71.93M 10-Q · filed 2023-05-10 | $178.28M derived: sum of 2 quarters · filed 2024-03-06 | $238.52M derived: sum of 3 quarters · filed 2024-03-06 | $322.00M derived: sum of 4 quarters · filed 2024-03-06 |
| 2021-12-31 | $106.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $166.59M derived: sum of 2 quarters · filed 2024-03-06 | $250.07M derived: sum of 3 quarters · filed 2024-03-06 | $302.99M 10-K · filed 2024-03-06 |
| 2021-09-30 | $60.24M 10-Q · filed 2022-11-08 | $143.72M derived: sum of 2 quarters · filed 2022-11-08 | $196.65M 10-Q · filed 2022-11-08 | $231.57M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $83.47M 10-Q · filed 2022-08-09 | $136.40M 10-Q · filed 2022-08-09 | $171.32M derived: sum of 3 quarters · filed 2022-08-09 | $207.89M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $52.93M 10-Q · filed 2022-05-10 | $87.85M derived: sum of 2 quarters · filed 2022-05-10 | $124.41M derived: sum of 3 quarters · filed 2022-05-10 | $157.86M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $34.92M 10-K · filed 2021-03-01 | $71.49M derived: sum of 2 quarters · filed 2021-11-09 | $104.93M derived: sum of 3 quarters · filed 2021-11-09 | $131.49M 10-K · filed 2023-03-01 |
| 2020-09-30 | $36.57M 10-Q · filed 2021-11-09 | $70.01M derived: sum of 2 quarters · filed 2021-11-09 | $96.57M 10-Q · filed 2021-11-09 | $127.27M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $33.45M 10-Q · filed 2021-08-09 | $60.01M 10-Q · filed 2021-08-09 | $90.71M derived: sum of 3 quarters · filed 2021-08-09 | $115.53M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $26.56M 10-Q · filed 2021-05-10 | $57.26M derived: sum of 2 quarters · filed 2021-05-10 | $82.08M derived: sum of 3 quarters · filed 2021-05-10 | $110.42M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $30.70M 10-K · filed 2021-03-01 | $55.52M derived: sum of 2 quarters · filed 2021-03-01 | $83.86M derived: sum of 3 quarters · filed 2021-03-01 | $115.22M 10-K · filed 2022-03-01 |
| 2019-09-30 | $24.82M 10-K · filed 2021-03-01 | $53.16M derived: sum of 2 quarters · filed 2021-03-01 | $84.52M 10-Q · filed 2020-11-09 | $116.52M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $28.34M 10-K · filed 2021-03-01 | $59.70M 10-Q · filed 2020-08-10 | $91.70M derived: sum of 3 quarters · filed 2021-03-01 | $120.35M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $31.36M 10-K · filed 2021-03-01 | $63.37M derived: sum of 2 quarters · filed 2021-03-01 | $92.01M derived: sum of 3 quarters · filed 2021-03-01 | $121.66M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $32.00M 10-K · filed 2020-03-12 | $60.65M derived: sum of 2 quarters · filed 2020-03-12 | $90.30M derived: sum of 3 quarters · filed 2020-03-12 | $124.57M 10-K · filed 2021-03-01 |
| 2018-09-30 | $28.64M 10-K · filed 2020-03-12 | $58.30M derived: sum of 2 quarters · filed 2020-03-12 | $92.57M 10-Q · filed 2019-11-12 | $124.25M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $29.65M 10-K · filed 2020-03-12 | $63.93M 10-Q · filed 2019-08-08 | $95.60M derived: sum of 3 quarters · filed 2020-03-12 | $127.43M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $34.28M 10-K · filed 2020-03-12 | $65.95M derived: sum of 2 quarters · filed 2020-03-12 | $97.78M derived: sum of 3 quarters · filed 2020-03-12 | $127.83M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $31.68M 10-K · filed 2019-03-12 | $63.51M derived: sum of 2 quarters · filed 2019-03-12 | $93.55M derived: sum of 3 quarters · filed 2019-03-12 | $125.86M 10-K · filed 2020-03-12 |
| 2017-09-30 | $31.83M 10-K · filed 2019-03-12 | $61.88M derived: sum of 2 quarters · filed 2019-03-12 | $94.19M 10-Q · filed 2018-11-08 | $125.07M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | $30.05M 10-K · filed 2019-03-12 | $62.36M 10-Q · filed 2018-08-07 | $93.24M derived: sum of 3 quarters · filed 2019-03-12 | $125.97M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $32.31M 10-K · filed 2019-03-12 | $63.19M derived: sum of 2 quarters · filed 2019-03-12 | $95.92M derived: sum of 3 quarters · filed 2019-03-12 | $120.35M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $30.88M 10-K · filed 2018-03-14 | $63.61M derived: sum of 2 quarters · filed 2018-03-14 | $88.04M derived: sum of 3 quarters · filed 2018-03-14 | $111.60M 10-K · filed 2019-03-12 |
| 2016-09-30 | $32.74M 10-K · filed 2018-03-14 | $57.17M derived: sum of 2 quarters · filed 2018-03-14 | $80.73M 10-Q · filed 2017-11-08 | $101.19M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $24.43M 10-K · filed 2018-03-14 | $47.99M 10-Q · filed 2017-08-08 | $68.45M derived: sum of 3 quarters · filed 2018-03-14 | $88.91M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $23.56M 10-K · filed 2018-03-14 | $44.02M derived: sum of 2 quarters · filed 2018-03-14 | $64.48M derived: sum of 3 quarters · filed 2018-03-14 | $84.88M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $20.46M 10-K · filed 2017-03-15 | $40.91M derived: sum of 2 quarters · filed 2017-03-15 | $61.32M derived: sum of 3 quarters · filed 2017-03-15 | $74.86M 10-K · filed 2018-03-14 |
| 2015-09-30 | $20.45M 10-K · filed 2017-03-15 | $40.86M derived: sum of 2 quarters · filed 2017-03-15 | $54.39M 10-Q · filed 2016-11-09 | $67.86M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $20.41M 10-K · filed 2017-03-15 | $33.94M 10-Q · filed 2016-08-08 | $47.41M derived: sum of 3 quarters · filed 2017-03-15 | $57.58M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $13.53M 10-K · filed 2017-03-15 | $27.00M derived: sum of 2 quarters · filed 2017-03-15 | $37.17M derived: sum of 3 quarters · filed 2017-03-15 | $51.13M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $13.47M 10-K · filed 2016-03-14 | $23.64M derived: sum of 2 quarters · filed 2016-03-14 | $37.60M derived: sum of 3 quarters · filed 2016-03-14 | $49.95M 10-K · filed 2017-03-15 |
| 2014-09-30 | $10.17M 10-K · filed 2016-03-14 | $24.13M derived: sum of 2 quarters · filed 2016-03-14 | $36.48M 10-Q · filed 2015-11-09 | $46.23M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $13.95M 10-K · filed 2016-03-14 | $26.31M 10-Q · filed 2015-08-10 | $36.06M derived: sum of 3 quarters · filed 2016-03-14 | $44.78M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $12.36M 10-K · filed 2016-03-14 | $22.10M derived: sum of 2 quarters · filed 2016-03-14 | $30.82M derived: sum of 3 quarters · filed 2016-03-14 | $37.28M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $9.74M 10-K · filed 2015-03-16 | $18.46M derived: sum of 2 quarters · filed 2015-03-16 | $24.92M derived: sum of 3 quarters · filed 2015-03-16 | $33.01M 10-K · filed 2016-03-14 |
| 2013-09-30 | $8.72M 10-K · filed 2015-03-16 | $15.18M derived: sum of 2 quarters · filed 2015-03-16 | $23.27M 10-Q · filed 2014-11-10 | $30.63M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $6.46M 10-K · filed 2015-03-16 | $14.55M 10-Q · filed 2014-08-11 | $21.91M derived: sum of 3 quarters · filed 2015-03-16 | $29.06M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $8.09M 10-K · filed 2015-03-16 | $15.45M derived: sum of 2 quarters · filed 2015-03-16 | $22.60M derived: sum of 3 quarters · filed 2015-03-16 | $29.82M derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $7.36M 10-K · filed 2014-03-17 | $14.51M derived: sum of 2 quarters · filed 2014-03-17 | $21.73M derived: sum of 3 quarters · filed 2014-03-17 | $27.61M 10-K · filed 2015-03-16 |
| 2012-09-30 | $7.15M 10-K · filed 2014-03-17 | $14.37M derived: sum of 2 quarters · filed 2014-03-17 | $20.25M 10-Q · filed 2013-11-12 | $27.66M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $7.22M 10-K · filed 2014-03-17 | $13.10M 10-Q · filed 2013-08-09 | $20.52M derived: sum of 3 quarters · filed 2014-03-17 | $29.49M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $5.88M 10-K · filed 2014-03-17 | $13.29M derived: sum of 2 quarters · filed 2014-03-17 | $22.27M derived: sum of 3 quarters · filed 2014-03-17 | $29.82M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $7.41M 10-K · filed 2013-03-18 | $16.39M derived: sum of 2 quarters · filed 2013-03-18 | $23.94M derived: sum of 3 quarters · filed 2013-03-18 | $31.43M 10-K · filed 2014-03-17 |
| 2011-09-30 | $8.97M 10-K · filed 2013-03-18 | $16.53M derived: sum of 2 quarters · filed 2013-03-18 | $24.02M 10-Q · filed 2012-11-07 | $31.66M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $7.56M 10-K · filed 2013-03-18 | $15.05M 10-Q · filed 2012-08-09 | $22.69M derived: sum of 3 quarters · filed 2013-03-18 | $28.52M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $7.49M 10-K · filed 2013-03-18 | $15.13M derived: sum of 2 quarters · filed 2013-03-18 | $20.96M derived: sum of 3 quarters · filed 2013-03-18 | $27.08M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $7.64M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $13.47M derived: sum of 2 quarters · filed 2013-03-18 | $19.58M derived: sum of 3 quarters · filed 2013-03-18 | $25.36M 10-K · filed 2013-03-18 |
| 2010-09-30 | $5.83M 10-Q · filed 2011-11-07 | $11.94M derived: sum of 2 quarters · filed 2011-11-07 | $17.72M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $6.11M 10-Q · filed 2011-08-05 | $11.89M 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | $23.08M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |